Activity of gemcitabine plus capecitabine in patients with metastatic breast cancer refractory to anthracyclines and taxanes

被引：0
|
作者：
Andres, R [1 ]
Matordomo, JI [1 ]
Polo, E [1 ]
Alvarez, I [1 ]
Lara, R [1 ]
Saenz, A [1 ]
Isla, D [1 ]
Escudero, P [1 ]
Tres, A [1 ]
机构：
[1] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
360
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [1] Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes
    Benekli, Mustafa
    Yildiz, Ramazan
    Uner, Aytug
    Er, Ozlem
    Yamac, Deniz
    Alkis, Necati
    Coskun, Ugur
    Camci, Celalettin
    Buyukberber, Suleyman
    [J]. ONCOLOGY, 2007, 72 (5-6) : 308 - 313
  • [2] Gemcitabine and Capecitabine Combination Chemotherapy in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and/or Taxanes
    Yao, Guangyu
    Cao, Li
    Liu, Mingfeng
    Chen, Lujia
    Hu, Xiaolei
    Ye, Changsheng
    [J]. CHEMOTHERAPY, 2015, 61 (04) : 171 - 178
  • [3] Phase II study of gemcitabine and capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
    Ahn, JH
    Kim, SB
    Lee, JS
    Kang, YK
    Kim, WK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 101S - 101S
  • [4] Bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.
    Schmid, P
    Schippinger, V
    Kiewe, P
    Lange, W
    Preiss, J
    Niederle, N
    Brossart, P
    Freier, W
    Van de Velde, H
    Possinger, K
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S68 - S69
  • [5] A phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes
    Estevez, Laura G.
    Batista, Norberto
    Sanchez-Rovira, Pedro
    Velasco, Amalia
    Provencio, Mariano
    Leon, Ana
    Domine, Manuel
    Cruz, Josefina
    Rodriguez, Milva
    [J]. CLINICAL BREAST CANCER, 2008, 8 (02) : 149 - 154
  • [6] A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanes
    Li, Qiao
    Li, Qing
    Zhang, Pin
    Yuan, Peng
    Wang, Jiayu
    Ma, Fei
    Luo, Yang
    Fan, Ying
    Cai, Ruigang
    Xu, Binghe
    [J]. CANCER BIOLOGY & THERAPY, 2015, 16 (12) : 1746 - 1753
  • [7] A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanes
    Li, Qiao
    Xu, Binghe
    Li, Qing
    Zhang, Pin
    Yuan, Peng
    Wang, Jiayu
    Ma, Fei
    Luo, Yang
    Fan, Ying
    Cai, Ruigang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] A prospective study of vinorelbine and capecitabine combination therapy in patients with metastatic breast cancer pretreated with anthracyclines and taxanes
    Xu, B.
    Fan, Y.
    Tian, L.
    Li, Q.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 283 - 283
  • [9] PHARMACOECONOMIC ANALISYS OF IXABEPILONE MONOTHERAPY IN PATIENTS WITH ADVANCED OR METASTATIC BREAST CANCER RESISTANT TO ANTHRACYCLINES, TAXANES AND CAPECITABINE
    Kolbin, A.
    Mosikian, A.
    Kmylev, A.
    Balykina, Y.
    Proskurin, M.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A440 - A440
  • [10] Gemcitabine plus irinotecan in breast cancer patients pretreated with taxanes and anthracyclines: A multicenter phase II study
    Agelaki, S
    Karyda, E
    Kouroussis, C
    Ardavanis, A
    Kalbakis, K
    Malas, K
    Malamos, N
    Alexopoulos, A
    Tselepatiotis, E
    Georgoulias, V
    [J]. ONCOLOGY, 2003, 64 (04) : 477 - 478
12345